Fulcrum Therapeutics, Inc. · NASDAQ:FULC

TCG Crossover GP II, LLC reported a 7.90% stake in Fulcrum Therapeutics, Inc. (Schedule 13G/A)

Event Mar 31, 2026 · Filed May 15, 2026

TCG Crossover GP II, LLC reported a 7.90% stake in Fulcrum Therapeutics, Inc., 5,250,000 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).

Stake
7.90%
Shares
5,250,000
Intent
Passive
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
TCG Crossover GP II, LLC7.90%5,250,000
TCG Crossover Fund II, L.P.7.90%5,250,000
Chen Yu7.90%5,250,000

Source

View original at SEC

Related